This study is looking at why some people with scleroderma (a disease that causes hardening of the skin and connective tissues) join clinical trials and others don't. It's an observational study, meaning you won't receive any new treatments, but researchers will gather information about your experiences. They want to understand what encourages or discourages people from different backgrounds to participate. The goal is to find patterns that can help future scleroderma patients get involved in research. To join, you need to be at least 18 years old, have a scleroderma diagnosis, and plan to enroll in an observational clinical trial. The study aims to enroll 500 participants, but its current status is unclear.

Study design

This is an observational study with a planned enrollment of 500 participants. It will analyze data from diverse demographic viewpoints.

What's involved

You would need to be able to perform regular electronic reporting. You would also need to understand, sign, and return a consent form.

Compensation

Not stated in the trial record.

Follow-up

The study will measure how many participants stay committed until the study wraps up, which is measured at 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.